|
Volumn 29, Issue 6, 2006, Pages 146-148
|
Can we deny patients expensive drugs?
a d b,c
d
NONE
|
Author keywords
Cost of drugs; Pharmaceutical Benefits Scheme
|
Indexed keywords
TUMOR NECROSIS FACTOR ANTIBODY;
ARTHRITIS;
BUDGET;
COST EFFECTIVENESS ANALYSIS;
CROHN DISEASE;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
MEDICAL DECISION MAKING;
PRESCRIPTION;
TREATMENT INDICATION;
|
EID: 33845911971
PISSN: 03128008
EISSN: None
Source Type: Journal
DOI: 10.18773/austprescr.2006.087 Document Type: Editorial |
Times cited : (9)
|
References (10)
|